Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Preferred Shares Issued Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Iridex (IRIX) Acquisitions (2021 - 2022)

Iridex has reported Acquisitions over the past 3 years, most recently at -$5.3 million for Q4 2022.

For Q4 2022, Acquisitions changed N/A year-over-year to -$5.3 million; the TTM value through Oct 2021 reached $5.3 million, changed N/A, while the annual FY2022 figure was $5.3 million, N/A changed from the prior year.
Acquisitions for Q4 2022 was -$5.3 million at Iridex, down from $5.3 million in the prior quarter.
Over five years, Acquisitions peaked at $5.3 million in Q2 2021 and troughed at -$5.3 million in Q4 2022.